Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / PHARMACEUTCL ETF
-
Number of holders
-
49
-
Total 13F shares, excl. options
-
775,415
-
Shares change
-
+41,956
-
Total reported value, excl. options
-
$56,458,804
-
Value change
-
+$3,053,753
-
Put/Call ratio
-
239%
-
Number of buys
-
19
-
Number of sells
-
-14
-
Price
-
$72.81
Significant Holders of VANECK ETF TRUST - PHARMACEUTCL ETF (PPH) as of Q3 2021
59 filings reported holding PPH - VANECK ETF TRUST - PHARMACEUTCL ETF as of Q3 2021.
VANECK ETF TRUST - PHARMACEUTCL ETF (PPH) has 49 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 775,415 shares
.
Largest 10 shareholders include GOLDMAN SACHS GROUP INC (147,127 shares), BANK OF AMERICA CORP /DE/ (125,141 shares), Clough Capital Partners L P (93,100 shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (68,848 shares), MORGAN STANLEY (59,815 shares), Orion Portfolio Solutions, LLC (56,547 shares), CITADEL ADVISORS LLC (49,015 shares), Tower Research Capital LLC (TRC) (17,803 shares), COMMONWEALTH EQUITY SERVICES, LLC (16,487 shares), and LPL Financial LLC (16,197 shares).
This table shows the top 49 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.